TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
BNR

Burning Rock Biotech Ltd

Healthcare · Diagnostics & Research

18.60$ +3.3% vs. previous close Closing price · As of: Sep 25, 2026

Ownership

Ownership Structure

Who owns Burning Rock Biotech Ltd (BNR)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 38.8% of the shares are freely tradable; institutional investors hold 46.6%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 46.6%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 4.0%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 38.8%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 0.5%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 9Mio.

Largest Shareholders

Institutions

Institutions BNR
Name Stake (%) Shares Change (%) Date
Kynam Capital Management, LP 11.74 1,238,563 +0.9 06/30/2026
CRCM LP 2.01 211,997 -24.8 06/30/2026
Renaissance Technologies Corp 0.34 35,407 +13.8 03/31/2026
Amova Asset Management Americas, Inc 0.28 29,724 -1.4 06/30/2026
Sumitomo Mitsui Trust Group Inc 0.28 29,724 -1.4 06/30/2026
Bank of America Corp 0.28 29,164 +0.0 03/31/2026
Citadel Advisors Llc 0.26 27,288 +54.4 06/30/2026
HSG Holding Ltd 0.20 21,212 +0.0 03/31/2026
Redwood Wealth Management Group LLC 0.17 18,278 -8.7 03/31/2026

Funds

Funds BNR
Name Stake (%) Shares Change (%) Date
Truvalue Glb Phrmctl Blgcl Eq (QDII) A 0.51 53,934 +22.3 06/30/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?